Please Note: This trial is no longer enrolling new participants
ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity
| Protocol No. | PHARM-IUSCCC-0913 | Scope | Local |
|---|---|---|---|
| Principal Investigator | Tyler Shugg | Treatment Type | Screening |
| Age Group | Adult | Phase | NA |
